Table IV.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
Factor | P-value | Risk ratio | 95% CI | P-value | |
Age (years) | 0.72 | ||||
≥83/<83 | |||||
Gender | 0.42 | ||||
Male/female | |||||
Alcohol abuse | 0.07 | ||||
Yes/no | |||||
Etiology | 0.93 | ||||
NBNC/HCV and/or HBV | |||||
Platelet count (104/µl) | 0.43 | ||||
≥15/<15 | |||||
Prothrombin activity (%) | 0.92 | ||||
≥90/<90 | |||||
AST (IU/l) | 0.44 | ||||
≥40/<40 | |||||
ALT (IU/l) | 0.20 | ||||
≥40/<40 | |||||
Total bilirubin (mg/dl) | 0.81 | ||||
≥0.7/<0.7 | |||||
Albumin (g/dl) | 0.17 | ||||
≥3.7/<3.7 | |||||
AFP (ng/ml) | 0.01 | 1.84 | 0.68–5.11 | 0.22 | |
≥14/<14 | |||||
DCP (mAU/ml) | 0.59 | ||||
≥200/<200 | |||||
ICGR15 (%) | 0.74 | ||||
≥15/<15 | |||||
Tumor number | <0.01 | 2.17 | 0.74–5.98 | 0.14 | |
Single/multiple | |||||
Maximum tumor size (cm) | 0.27 | ||||
≥4/<4 | |||||
Blood transfusion | 0.85 | ||||
Yes/no | |||||
Post-operative complications | 0.02 | 4.30 | 1.49–13.25 | <0.01 | |
Yes/no |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; ICGR-15, indocyanine green retention rate at 15 min; AFP, α-fetoprotein; DCP, des-gamma-carboxy prothrombin; HCV, hepatitis C virus; HBV, hepatitis B virus; NBNC, negative for HBV and HCV; CI, confidence interval.